HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Hepatocellular jaundice — Clinical Guidelines

Overview

Hepatocellular jaundice results from impaired bilirubin metabolism or excretion, often due to liver dysfunction or biliary obstruction, presenting clinically with yellowing of the skin and sclera. 1

Diagnosis

Clinical Presentation: Yellow discoloration of skin and sclera, dark urine, pale stools, and potential pruritus. 1

Laboratory Tests: Elevated total and direct bilirubin levels, abnormal liver function tests (AST, ALT, ALP, GGT). 1 5

Imaging: Ultrasound, CT, MRI, or MRCP to identify structural causes like gallstones, tumors, or cysts. 4 7 10

Endoscopic Procedures: ERCP for direct visualization and intervention in suspected biliary obstruction. 4 6

Special Considerations: Unilateral scleral jaundice may indicate rare pathologies requiring thorough investigation. 3

Management

Address Underlying Cause: Surgical intervention for mechanical obstruction (e.g., gallstones, cysts, hydatid cysts). 6 7 10

Medical Management: Intravenous antibiotics for infections, cessation of causative drugs (e.g., captopril). 8 9

Supportive Care: Hydration, nutritional support, and management of complications like cholangitis. 1

Minimally Invasive Techniques: Percutaneous cholecystostomy for inspissated bile syndrome in neonates and infants. 2

Lipid Management: Monitoring and managing abnormal lipoprotein profiles in obstructive jaundice. 11 12

Special Populations

Pediatrics: Inspissated bile syndrome may require minimally invasive drainage techniques. 2

Elderly: Increased vigilance for complications and underlying comorbidities affecting jaundice management. 1

Comorbidities: Portal vein thrombosis can cause intramural varices leading to biliary obstruction, requiring careful imaging and management. 4

Key Recommendations

Conduct a thorough diagnostic workup including laboratory tests and imaging to identify the cause of jaundice, (Evidence: Strong 1 4 5)

Prioritize surgical or endoscopic intervention for mechanical biliary obstruction to prevent complications, (Evidence: Strong 6 7 10)

Consider minimally invasive procedures like percutaneous cholecystostomy for neonates with inspissated bile syndrome, (Evidence: Moderate 2)

Evaluate and manage potential drug-induced causes by discontinuing offending agents, (Evidence: Weak 8 9)

Monitor and address abnormal lipoprotein profiles in patients with obstructive jaundice, (Evidence: Weak 11 12)

References

1 Taylor T, Wheatley M, Gupta N, Nusbaum J. Jaundice in the emergency department: meeting the challenges of diagnosis and treatment [digest]. Emergency medicine practice 2018. link 2 Bollu BK, Dawrant MJ, Thacker K, Thomas G, Chenapragadda M, Gaskin K et al.. Inspissated bile syndrome; Safe and effective minimally invasive treatment with percutaneous cholecystostomy in neonates and infants. Journal of pediatric surgery 2016. link 3 Isa SE, Asalu AF. Scleral jaundice may be unilateral: a case report. Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria 2011. link 4 Grgurević I, Buljevac M, Kujundzić M, Vukelić-Marković M, Kardum D, Brkljacić B. Common bile duct wall thickening due to intramural varices diagnosed by colour Doppler ultrasound. Ultraschall in der Medizin (Stuttgart, Germany : 1980) 2006. link 5 Whitehead MW, Hainsworth I, Kingham JG. The causes of obvious jaundice in South West Wales: perceptions versus reality. Gut 2001. link 6 Kumar A, Gautam A, Chaturvedi S. Obstructive jaundice due to Fasciola hepatica. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 1995. link 7 Woudstra M, Scherpenisse J, Winter LH. Hepatocholedochal cysts. A rare cause of obstructive jaundice. The Netherlands journal of medicine 1993. link 8 Hagley MT. Captopril-induced cholestatic jaundice. Southern medical journal 1991. link 9 Gur I, Vinograd I, Dgani Y, Arad I. Obstructive jaundice due to inspissated bile following disseminated intravascular coagulation. Israel journal of medical sciences 1986. link 10 Thomson RL. Obstructive jaundice due to hydatid cyst of the liver. The Medical journal of Australia 1978. link 11 Seidel D, Alaupovic P, Furman RH, McConathy WJ. A lipoprotein characterizing obstructive jaundice. II. Isolation and partial characterization of the protein moieties of low density lipoproteins. The Journal of clinical investigation 1970. link 12 Seidel D, Alaupovic P, Furman RH. A lipoprotein characterizing obstructive jaundice. I. Method for quantitative separation and identification of lipoproteins in jaundiced subjects. The Journal of clinical investigation 1969. link

Hepatocellular jaundice